Search Results

Mark Connor Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins ), Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with

Flash News → terrys corner from data to insight Published on July 14, 2025 Category Terry's Corner Pharmacology stronger pipelines and those rethinking legacy models. ✳️ https://www.terrykenakin.com #GPCR #DrGPCR #pharmacology

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994). He has also received both Junior (2001) and Senior (2005) investigator awards from the Pharmacological Society of Canada.

event-details-registration/practical-quantification-of-allosteric-modulation #GPCR #Allostery #DrugDiscovery #Pharmacology event-details-registration/practical-quantification-of-allosteric-modulation #GPCR #Allostery #DrugDiscovery #Pharmacology

In his latest lesson, he breaks down the essential models shaping modern pharmacology. ✳️ https://www.terrykenakin.com #pharmacology #drugmechanism #kenakin #GPCR #DrGPCR Previous Next Recent

Pharmacy from Minia University in 2011 and began my career as a teaching and research assistant in Pharmacology Later, I completed my Master's degree in Pharmacology at Minia University, focusing on hydrogen sulfide's as a visiting graduate student, and in September 2022, I enrolled in the direct-entry Physiology and Pharmacology I employ a multidisciplinary approach that combines molecular pharmacology, biochemical assays, and biophysical GPCR Title: Antibodies Expand the Scope of Angiotensin Receptor Pharmacology About Meredith Skiba "Meredith

In Terry’s Corner latest lesson, discover how pharmacologic models do just that. www.ecosystem.drgpcr.com/post/what-if-you-could-predict-drug-behavior-with-just-a-snapshot #GPCR #DrGPCR #pharmacology

Home Courses Articles About Log In / Sign Up Terry's Pharmacology Corner Lost in GPCR Complexity? Matters Join Monthly AMAs with Terry Unlock 40+ Years of Expertise Master GPCRs with Precision Terry’s Pharmacology Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge Expert-Level Mastery — Advanced Pharmacology Live AMA Sessions with Terry

mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology

Biochemistry: Unique Biased Agonism Profile of βCGRP on CGRP Family Receptors #GPCR #CGRP #DrugDiscovery #Pharmacology Biochemistry : Unique Biased Agonism Profile of βCGRP on CGRP Family Receptors #GPCR #CGRP #DrugDiscovery #Pharmacology

Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab research awards, including the William James Psychology Award, the Hank Yamamura Endowed Fellowship in Pharmacology She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug Discovery. In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology

more than 25 years of experience in drug development. have been engaged in GPCR cellular and clinical pharmacology I have participated and initiated methodologies for development of pharmacologically active anti-GPCR have published or contributed in 38 published scientific work mainly in the field of immunology and pharmacology

graduate research on the regulation of axonal transport by tricyclic antidepressants (M.Sc.) and molecular pharmacology of opioid receptors (Ph.D.) in the Department of Pharmacology at the Université de Montréal under the The Tiberi Lab pursues the study of the molecular, structural, pharmacological and signaling features

Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

Adriano received his Bachelor of Science degree in Pharmacology in 1991 from the University of Toronto his graduate studies at the University of Toronto where he earned his MSc (1994) and Ph.D. (1998) in Pharmacology In 2004 Adriano joined the faculty of the Department of Pharmacology at Loyola University Chicago.

Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine. studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge of GPCRs pharmacology discovery and adopt data science methodology to tackle relevant scientific questions on the systems pharmacology

postdoctoral fellow at the University of Michigan, joins the conversation as a rising voice in GPCR pharmacology GPCRs and the Opioid Crisis: A New Pharmacological Frontier Now at the University of Michigan, Ben focuses Scientific Rigor: The Value of ‘Old School’ Pharmacology Despite the availability of modern tools, Ben Using site-directed mutagenesis and pharmacological synergy assays , his team aims to understand how This project involves molecular pharmacology in cell models to determine binding sites and mechanisms

Explore the Masterclass Pharmacology Foundations Build the essential lens every scientist needs to see pharmacology clearly, from core principles to the hidden variables of drug disposition. Agonists, Antagonists & Core Mechanisms Master the classic players in GPCR pharmacology and learn how The classes are designed for researchers, students, and professionals in biology, pharmacology, and biochemistry Masterclasses cover a variety of track including but not limited to p harmacology foundations, agonists

Summary made with AI About Dmitry Veprintsev Dmitry is Professor of Molecular and Cellular Pharmacology Receptors (COMPARE), University of Nottingham, where he provides leadership in structural and biophysical pharmacology at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural pharmacology 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision pharmacology

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro Pharmacology

How GPCR pharmacology connects molecular insights to real-world interventions. how fentanyl and xylazine shut down breathing through different mechanisms—work that blends receptor pharmacology now and see how one scientist is turning molecules into a mission, bridging the gap between receptor pharmacology GPCR ecosystem , GPCR training program , GPCR podcast , opioid pharmacology , xylazine research , mu opioid receptor , pharmacogenomics , fentanyl epidemic , preclinical pharmacology Enjoying the Dr.

Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute of Pharmacology He received a Ph.D. in pharmacology in 1992 from the Russian Academy of Medical Sciences and an M.D. Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology

Welcome to Flash News—your fastest track to the latest updates in GPCR research, pharmacology, and biotechnology From reluctant intern to scientific leader From local signaling to spatial pharmacology From spark to Terry’s Corner was built to make advanced pharmacology practical: a space where scientists don’t just #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Biotech #AllostericModulation #Kinetics #AssayDevelopment October 27, 2025 Terry's Corner Read full article Receptor pharmacology has evolved.

Caron is also past Associate Editor at JCI and served as the inaugural Associate Editor at ACS-Pharmacology Lauren Slosky "Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

papers on lipid-rich domains and GPCR–G protein compartmentalization reframed her view of receptor pharmacology papers on lipid-rich domains and GPCR–G protein compartmentalization reframed her view of receptor pharmacology

elegant mechanistic biology with translational impact — giving us new ways to think about receptor pharmacology GPCR Premium → https://www.ecosystem.drgpcr.com/gpcr-university #GPCR #DrGPCR #pharmacology #drugdiscovery

Soon About Louis Gendron "Dr Louis Gendron, PhD is tenured Professor and Chair of the Department of Pharmacology-Physiology He has 20+ years of experience in in vitro and in vivo GPCR pharmacology and has published seminal papers

Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging

Debbie Hay is presently a professor at the Department of Pharmacology and Toxicology at the University Debbie obtained a Ph.D. in Molecular Pharmacology from Imperial College London in the UK.